Heron Therapeutics COO acquires 11,770 shares

Q: What did HRTX COO Mark Earl Hensley report on October 30, 2026?

Mark Earl Hensley reported exercising 11,770 RSUs for 11,770 common shares and delivering or withholding 3,349 shares for payment of exercise price or tax liability at $0.28 per share. No Rule 10b5-1 plan was reported.

Q: How do Mark Earl Hensley’s HRTX RSUs vest?

Hensley received a grant of 188,315 RSUs on January 30, 2026. They vest in 16 equal quarterly installments, beginning one quarter after the grant date.

The RSUs were part of a 188,315-unit grant with 16 equal quarterly vesting installments beginning one quarter after January 30, 2026.

Available on EDGAR 11/03/2026 - 12:50 PM EST Accepted by SEC EDGAR 11/03/2026 - 12:50 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Heron Therapeutics, Inc. (HRTX) reported that Chief Operating Officer Mark Earl Hensley exercised 11,770 restricted stock units for 11,770 common shares on October 30, 2026. On that date, 3,349 shares were delivered or withheld for payment of exercise price or tax liability, at a reported price of $0.28 per share. Hensley reported holding 153,006 RSUs following the transaction. No Rule 10b5-1 plan was reported.

Insider Trade Summary

11,770 shares exercised/converted

Exercise 3 txns

Insider Hensley Mark Earl

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units ^F2	11,770	$0.00	$0.00
Exercise	Common Stock ^F1	11,770	--	--
Exercise Price or Tax Liability	Common Stock	3,349	$0.28	$937.72

Holdings After Transaction: Restricted Stock Units — 153,006 contracts (Direct); Common Stock — 179,322 shares (Direct)

Holdings Before and After: Restricted Stock Units, 164,776 to 153,006 contracts (Direct); Common Stock, 170,901 to 179,322 shares (Direct)

Footnotes (2)

F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
F2. On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant.

Key Figures

RSUs exercised: 11,770 RSUs Common shares acquired: 11,770 shares Shares delivered or withheld: 3,349 shares +4 more

7 metrics

RSUs exercised 11,770 RSUs October 30, 2026

Common shares acquired 11,770 shares October 30, 2026

Shares delivered or withheld 3,349 shares For payment of exercise price or tax liability on October 30, 2026

Reported price per share $0.28 per share Shares delivered or withheld on October 30, 2026

RSUs following transaction 153,006 RSUs Following the October 30, 2026 transaction

RSU grant 188,315 RSUs Granted January 30, 2026

Vesting installments 16 equal quarterly installments Beginning one quarter after the January 30, 2026 grant date

Key Terms

Restricted Stock Units, contingent right, time-based vesting schedule

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share of common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"a contingent right to receive one share of common stock"

time-based vesting schedule financial

"vest upon the following time-based vesting schedule"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HRTX COO Mark Earl Hensley report on October 30, 2026?

Mark Earl Hensley reported exercising 11,770 RSUs for 11,770 common shares and delivering or withholding 3,349 shares for payment of exercise price or tax liability at $0.28 per share. No Rule 10b5-1 plan was reported.

How do Mark Earl Hensley’s HRTX RSUs vest?

Hensley received a grant of 188,315 RSUs on January 30, 2026. They vest in 16 equal quarterly installments, beginning one quarter after the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hensley Mark Earl

(Last)

(First)

(Middle)

25 FENTON MAIN STREET

SUITE 300

(Street)

CARY

NORTH CAROLINA

27511

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HERON THERAPEUTICS, INC. /DE/ [ HRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/30/2026		M		11,770	A	⁽¹⁾	182,671	D
Common Stock	10/30/2026		F		3,349	D	$0.28	179,322	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0	10/30/2026		M			11,770	⁽²⁾	⁽²⁾	Common Stock	11,770	$0	153,006	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock.

2. On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant.

	/s/Kathryn Lester Attorney-in-fact for Mark E. Hensley	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR